VANCOUVER, British Columbia – Nov. 18, 2019 /AxisWire/ – Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace, reports that engineers have completed assembly of a handheld portable version of the (UBC) THC Breath Analyzer and are preparing the device to build upon promising human tests conducted earlier this year in Kelowna BC.  Over the last several weeks, Company engineers have reduced the size of several components inside the THCBA for a compact handheld device.  Cannabix has been conducting extensive lab testing with the new device. The THC Breath Analyzer (“THCBA”) incorporates sensitive microfluidic sensor technology for the detection of ∆9-tetrahydrocannabinol (“THC”) from breath. Furthermore, several software upgrades are being completed to use cloud-based machine learning (ML) techniques to process data more quickly. Initial ML analysis will be performed by experts at UBC. Cannabix is commissioning several additional units in the short term and expects that these devices will be available for broader multisite testing this winter. The Company has made the first pictures of the newly built THCBA available on its website at cannabixtechnologies.com.   

Dr. Mina Hoorfar stated, “We have been working hard in collaboration with Cannabix to optimize the device and its components.  Our mutual goal continues to be developing an affordable, portable, fast and accurate device for use with a range of potential users.”

Rav Mlait, CEO, stated, “Our team has been working intensely on our devices for the law enforcement and workplace markets. Several additional police, private and government related agencies have been in touch with Cannabix this fall, showing interest in piloting our devices, as marijuana use for recreational and medical purposes is expanding across various jurisdictions in the United States and we have surpassed one year of recreational use across Canada. Furthermore, we are seeing police and others becoming more open to new technologies related to cannabis impairment detection. We are very excited for the additional prospects for the THCBA because of its single stage, direct breath capability, compact portable design and ability to provide results quickly.”

The Company reports that it has improved several components within its FAIMS (field asymmetric waveform ion mobility spectrometry) THC detection device. More recently, engineers have enhanced sample flow conditions within the unit, worked intensely on ion optics and are testing a new multi-plate detector unit. The Company is also pleased to report that it has been testing with both direct breath and breath collection methods using the FAIMS system.   

About Cannabix Technologies Inc.

Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace. Cannabix has established breath testing technologies in the pursuit of bringing durable, portable tools to market to enhance detection of marijuana impaired driving offences on roads at a time when marijuana is becoming legal in many global jurisdictions. Cannabix is working to develop drug-testing devices that will detect THC- the psychoactive component of marijuana that causes intoxication- using breath samples. In particular, Cannabix is focused on developing breath testing devices for detection of recent use of THC, in contrast to urine testing for THC metabolite that requires an invasive collection and reflects usage, days or even weeks earlier. The devices will also be useful for other practical applications such as testing employees in the workplace where impairment by THC can be hazardous.

We seek Safe Harbor.  

On behalf of the Board of Directors

“Rav Mlait”

CEO
Cannabix Technologies Inc.

For further information, contact the Company at info@cannabixtechnologies.com

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company, such as final development of a commercial or prototype product(s), successful trial or pilot of company technologies, no assurance that commercial sales of any kind actually materialize; no assurance the Company will have sufficient funds to complete product development. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks regarding protection of proprietary technology; (iii) the ability of the Company to complete financings; (iv) the ability of the Company to develop and market its future product; and (v) risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the marijuana breathalyzer business will provide any benefit to the Company, and no assurance that any proposed new products will be built or proceed. There is no assurance that existing “patent pending” technologies licensed by the Company will receive patent status by regulatory authorities.  The Company is not currently selling commercial breathalyzers. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.

Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/7b2b7abe-c822-4f94-88fa-6e1fe4000572

https://www.globenewswire.com/NewsRoom/AttachmentNg/033527bd-5fa4-47fa-b7fb-ff3b29bd666b

https://www.globenewswire.com/NewsRoom/AttachmentNg/fbc8c8c2-865b-4558-bd10-d50203eb4702

Media Inquiries:


You Just Read:

Cannabix Technologies Reaches Development Milestone with Marijuana Breathalyzer Devices – Provides New Pictures